investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC
Dihua Yu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Dihua Yu
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
William G Cance
Focal Adhesion Kinase - Tumor Biology and Therapeutics
Breast
Maria Jasin
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES
Breast
Chandra Bartholomeusz
Development of Targeted Therapy for ERK Pathway in Breast Cancer
Breast
Fabio Petrocca
Noxa-mediated mechanisms of proteasome addiction in basal-like breast cancer
Breast
Joe W Gray
Model-based Predictions of Responses RTK Pathway Therapies
Breast
Sendurai A Mani
Pleiotropic Functions of FOXC2 in EMT, Stem Cells and Breast Cancer Progression
Breast
Lauren E Burkard
Mechanisms of Macrophage-Mediated Tumor Metastasis
Breast
Christopher B Umbricht
Multicenter Genetic, Epigenetic and Expression Analysis of DCIS outcome predictors
Breast
Zhiyuan Shen
Alternative Mechanisms to Inactivate p53 During Oncogenesis
Breast
